Evidence map›Paper›PMID 41563488›Full record

ArticleJournal of neurology2026

Three years later: tracking bothersome symptoms and impacts for people with early Parkinson's disease.

Jennifer R Mammen, Varun Reddy, Aaron Lerner, Nami Shah, Jocelyn Silva, Mirinda Tyo, Kristin Magan, Nguyen Thimaikhue, Dang Thao-Uyen, Tatiana Solodova and 7 more

Abstract read
In one paragraph

Article in Journal of neurology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

17 authors.

Jennifer R MammenDartmouth College of Nursing and Health Sciences, University of Massachusetts, 285 Old Westport Rd, Dartmouth, MA, USA. jmammen@umassd.edu.ORCID http://orcid.org/0000-0001-7858-9183
Varun ReddyCenter for Health + Technology, University of Rochester Medical Center, Rochester, NY, USA.
Aaron LernerCenter for Health + Technology, University of Rochester Medical Center, Rochester, NY, USA.
Nami ShahCenter for Health + Technology, University of Rochester Medical Center, Rochester, NY, USA.
Jocelyn SilvaDartmouth College of Nursing and Health Sciences, University of Massachusetts, 285 Old Westport Rd, Dartmouth, MA, USA.
Mirinda TyoDartmouth College of Nursing and Health Sciences, University of Massachusetts, 285 Old Westport Rd, Dartmouth, MA, USA.
Kristin MaganDartmouth College of Nursing and Health Sciences, University of Massachusetts, 285 Old Westport Rd, Dartmouth, MA, USA.
Nguyen ThimaikhueCenter for Health + Technology, University of Rochester Medical Center, Rochester, NY, USA.
Dang Thao-UyenCenter for Health + Technology, University of Rochester Medical Center, Rochester, NY, USA.
Tatiana SolodovaCenter for Health + Technology, University of Rochester Medical Center, Rochester, NY, USA.
Tim McWilliamsDepartment of Neurology, Medical Center, University of Rochester, Rochester, NY, USA.
Mathew StephenDepartment of Neurology, Medical Center, University of Rochester, Rochester, NY, USA.
Peggy AuingerCenter for Health + Technology, University of Rochester Medical Center, Rochester, NY, USA.
Melissa KostrzebskiCenter for Health + Technology, University of Rochester Medical Center, Rochester, NY, USA.
Yuge XiaoMichael J Fox Foundation for Parkinson's Research, Newyork, USA.
Diane StephensonCritical Path for Parkinson's, Tucson, AZ, USA.
Jamie L AdamsCenter for Health + Technology, University of Rochester Medical Center, Rochester, NY, USA.

Funding

Michael J. Fox Foundation for Parkinson's Research MJFF-022743Michael J. Fox Foundation for Parkinson's Research MJFF-024503
6 · The paper itself

Abstract

backgroundUnderstanding how meaningful symptoms and impacts of Parkinson's change with time is necessary to select endpoints for clinical trials and to support clinical practice.

objectiveThis study aimed to longitudinally evaluate the prevalence, bothersomeness, and functional impacts of early Parkinson's symptoms on daily life over a three-year study duration.

methods32 participants with early Parkinson's completed qualitative interviews to map symptoms and impacts of disease annually for three years. Symptom maps were content coded for frequency and bothersomeness of symptoms and presence of related impacts. Non-parametric generalized linear mixed models (GLMM) were used to evaluate change over time.

resultsThe most bothersome motor symptoms were tremor, gait difficulties, balance, fine motor, slow movements, and stiffness at all years. Top non-motor symptoms were fatigue, sleep, mood changes, difficulty thinking, and quiet voice. Of these, only gait and balance changed significantly over the study duration. By contrast, many functional impacts changed significantly, with all reporting increased work of living and greater effort to do usual activities by year 3. At the same time, participants reported increased ability to cope and compensate by making positive life changes which mitigated the bothersomeness of symptoms.

conclusionsOther than gait and balance, few Parkinson's symptoms increased significantly in bothersomeness over three years. However, functional and psychosocial impacts of symptoms, often attributed to more than one cause, were more sensitive to change over time.

Indexed as

Activities of Daily LivingParkinson DiseaseAgedDisease ProgressionFemaleHumansLongitudinal StudiesMaleMiddle AgedSymptom BurdenImpactsLongitudinalParkinson’sQualitativeSymptoms

Identifiers

PMID41563488
PMCPMC12823644

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.